Compare Charles River Laboratories Intl. Inc (CRL) vs IQVIA Holdings Inc. Common Stock (IQV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs IQVIA Holdings Inc. Common Stock — how do they compare? Charles River Laboratories Intl. Inc trades at $302.69 (market cap $14.23B), while IQVIA Holdings Inc. Common Stock trades at $261.91 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 3× Charles River Laboratories Intl. Inc's market cap, and IQVIA Holdings Inc. Common Stock is more actively traded (988,398 versus 1,176,885). Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and IQVIA Holdings Inc. Common Stock for 0 Days on average.
| CRL | IQV | |
|---|---|---|
Market Cap | $14.23B | $42.61B |
Volume | 1,176,885 | 988,398 |
Sector | Health | Health |
52-Week High | $310.77 | $275.02 |
52-Week Low | $149.93 | $156.66 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $17.06B | $56.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About IQVIA Holdings Inc. Common Stock
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →
